A recent report provides new insights into the mechanisms of neurodegeneration. In a mouse mutant with progressive cerebellar and retinal degeneration, the expression of the apoptotic protein AIF was found to be downregulated leading paradoxically to apoptosis of neurons that is associated with an imbalance in free radical metabolism and cell cycle re-entry.
The study of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, is an exciting area of current biological research. Novel insights into the mechanisms that underlie neurodegeneration are coming from a number of approaches including, as shown in a recent article in Nature, studies of mice with inherited spontaneous mutations [1] . By characterizing the genetic and biochemical abnormalities in a mouse neurodegenerative mutant termed harlequin, Susan Ackerman and colleagues link oxidative stress in the adult brain with cell cycle reactivation and apoptosis of postmitotic neurons. And in the process, the Ackerman group has helped uncover a novel function for the mitochondrial protein apoptosis-inducing factor (AIF).
The Harlequin Mouse: Ataxia with low AIF
The harlequin mouse was first described as an Xlinked mutant mouse with little hair [2] . But it was the phenotype of progressive ataxia that caught the attention of investigators at the Jackson Laboratory who described the cerebellar pathology that correlates with this phenotype [3] . In the recent work [1] , the molecular genetic abnormality responsible for the harlequin mouse was mapped by positional cloning. The expression of one candidate gene, encoding apoptosisinducing factor (AIF), was found to be reduced by 80% in the harlequin mouse due to an insertion of a mouse leukemia virus in the AIF locus. As AIF had been previously described to be pro-apoptotic, the genetic findings left the authors with the paradoxical question of how a reduction in the level of a pro-apoptotic protein triggers neuronal cell death and degeneration.
AIF as an Apoptosis Inducer AIF was first identified by Guido Kroemer's group as a mitochondrial protein that induces apoptosis in a caspase-independent manner [4] . Stimuli that lead to apoptosis were found to promote the translocation of AIF from the mitochondria to the cytosol and nucleus [4] . Once in the nucleus, AIF imparts a powerful apoptotic signal that leads to chromatin condensation and DNA fragmentation. The crystal structure of AIF revealed a surface with positive electrostatic potential that may mediate AIF's ability to bind to DNA in a sequence-independent manner leading to large-scale DNA cleavage [5] . That AIF is an important mediator of apoptosis was confirmed in genetic studies: AIF-deficient embryonic stem cells are resistant to serum deprivation-induced apoptosis and the first wave of apoptosis during embryogenesis is defective in the AIFdeficient mouse embryos [6] .
How apoptotic signals trigger AIF release remains to be elucidated at this point. Apoptotic stimuli, including free radicals, that induce DNA damage and activate poly ADP-ribose polymerase (PARP) in the nucleus have recently been suggested to trigger the release of AIF from mitochondria as a secondary consequence of consumption of the metabolite nicotinamide adenine dinucleotide (NAD + ) [7] . However, how the alteration in NAD metabolism is involved in the translocation of AIF from the mitochondria to the nucleus remains unclear.
AIF as an Oxidoreductase
While AIF's role as an apoptotic protein is beginning to be characterized, the Nature study has elevated the status of another function of AIF that has so far received little attention. Presumably, a reduction in the apoptosis-inducing function of AIF does not explain the progressive neuronal degeneration in the harlequin mouse. A clue as to how a hypomorphic allele of AIF might trigger neurodegeneration comes from molecular, structural and biochemical studies of AIF. The molecular characterization of AIF suggested that AIF contains a domain related in sequence to bacterial oxidoreductases [4] . Crystallographic studies of AIF revealed the presence of an oxidoreductase domain that resembles the ferrodoxin reductase component of bacterial biphenyl dioxygenases [8] . In biochemical studies, the oxidoreductase domain of AIF was demonstrated to harbor NAD(P)H oxidase activity in vitro [9] . Interestingly, the apoptotic and NAD(P)H oxidase activities of AIF were found to operate independently of each other [9] . These data suggest that AIF is a bifunctional protein whose oxidoreductase activity might participate in the function of AIF in mitochondria. However, the precise physiological role of AIF in mitochondria remains to be elucidated.
In examining potential mechanisms that underlie the progressive cerebellar neurodegeneration in the harlequin mouse, the Ackerman group followed the hypothesis that the low expression of AIF leads to the impairment of free radical homeostasis and consequent oxidative stress in neurons. Based on the comparison of AIF to hydrogen peroxide scavenging bacterial oxidoreductases, the authors proposed that low AIF leads to the accumulation of hydrogen peroxide. Consistent with Ackerman's hypothesis, the harlequin mouse contains increased lipid peroxidation and compensatory increases in the activity of catalase and glutathione reductase [1] . However, several questions remain in the interpretation of the reported data on free radical homeostasis in the harlequin mice. The physiological substrates of AIF's oxidoreductase activity in the mitochondria and thus the reactive oxygen species that are increased in AIF-deficient neurons are currently unknown [9] . Although AIF has NAD(P)H oxidase activity in vitro that generates superoxide anion radicals, NAD(P)H may not be the true substrate of AIF in vivo [9] . The lowering of such an activity in AIF-deficient cells would be expected to reduce rather than raise the free radical load in the cell [10] . Importantly, AIF has been suggested not to have hydrogen peroxide scavenging activity in vitro presenting a contradiction to the hypothesis proposed in the Nature study [9] . Supporting Ackerman's hypothesis that abnormalities in free radical pathways contribute to the degeneration of AIF-deficient neurons is the evidence of increased and selective sensitivity of cultured harlequin cerebellar granule neurons to hydrogen peroxideinduced apoptosis, a phenotype that is rescued by the expression of AIF [1] . To help establish the link between loss of AIF's oxidoreductase activity and neurodegeneration, it will be important to test the effect of mutating the oxidoreductase domain of AIF on AIF's ability to rescue granule neurons from hydrogen peroxide-induced apoptosis.
Harlequin Mouse Neurons Re-enter the Cell Cycle
One of the most interesting aspects of the study on the harlequin mouse is that the cell cycle machinery is reactivated in the degenerating postmitotic neurons as shown by the incorporation of bromodeoxyuridine and the expression of DNA replication proteins in these neurons [1] . Based on these data, the Ackerman group proposed the model whereby oxidative stress in the harlequin mouse instructs susceptible neurons to resume the cell cycle only to succumb to apoptosis.
The hypothesis that abortive cell cycle re-entry might be a fundamental mechanism by which postmitotic neurons undergo apoptosis was formulated some time ago in studies of developmentally regulated neuronal apoptosis (reviewed in [11] ). The withdrawal of neurotrophic factors or neuronal activity from the extracellular environment of postmitotic neurons in the developing brain triggers the activation of G1/S components of the cell cycle in neurons including the phosphorylation of the retinoblastoma protein and the consequent activation of the transcription factor E2F. In addition to the activation of G1/S cell cycle components, recent results indicate that G2/M cell cycle proteins are also activated in dying neurons. The mitotic kinase Cdc2 mediates apoptosis of activity-deprived cerebellar granule neurons by directly phosphorylating and activating a component of the cell death machinery [12] .
Accumulating evidence also suggests that neurons in the adult brain re-enter the cell cycle upon exposure to pathogenic stimuli that induce neuronal degeneration. In patients afflicted with Alzheimer's disease and other neurodegenerative diseases of the brain, evidence of reactivation of the mitotic machinery is suggested by the presence of immunoreactivity of Cdc2 and its activator cyclin B1 in degenerating forebrain neurons [13] [14] [15] . Interestingly, evidence of DNA synthesis and replication per se has been sparse in human neurodegenerations but may occur in Alzheimer's disease [16] . Although evidence of cell cycle re-entry appears often in neurodegenerative diseases, the mechanisms by which pathogenic stimuli trigger cell cycle re-entry are not yet clear. In addition and more importantly, the role of cell cycle reactivation in triggering neuronal cell death and degeneration in these disorders remains unknown.
In the harlequin mouse, AIF-deficient cerebellar granule neurons appear to undergo DNA synthesis and replication in large numbers [1] . It will be interesting to determine if the robust DNA replication observed in AIF-deficient mouse cerebellar granule neurons is a process that occurs generally in neurodegenerative diseases. The Ackerman group correlates the response of neurons to oxidative stress and the reactivation of the cell cycle. However, the molecular links between oxidative stress and cell cycle re-entry in neurons have yet to be characterized. In addition, it remains to be determined whether cell cycle re-entry constitutes the mechanism by which AIF deficiency triggers neuronal degeneration and apoptosis in the harlequin mouse.
Perspectives
The Nature study raises the possibility that the investigation of mouse mutants might be valuable to the study of degenerative diseases of the human brain in a similar manner as spontaneous mouse mutants have 
